Oncocross strives to develop treatments for intractable and rare diseases with their transcriptome data-based AI platforms and drug discovery pipelines. Oncocross’s main proprietary AI platforms are RAPTOR AI™ for drug development, and ONCO-RAPTOR AI™ for the identification of optimal indications of anticancer drugs and companion diagnostic biomarkers.